HomeMarkets overviewSharesTransMedics Group Inc

Trade TransMedics Group Inc - TMDX CFD

Market is not available at the momentMarket information is presented
as of 2026-10-07T19:47:36+00:00
Trading Conditions
Type
This financial market is available for CFD trading.
Learn more about:CFDs
CFD
Spread0.32
Long position overnight funding adjustment
Long position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
-0.022262 %
(-$4.45)

Trade size with leverage ~ $20,000.00

Money from leverage ~ $19,000.00


-0.02226%
Short position overnight funding adjustment
Short position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
0.00004 %
($0.01)

Trade size with leverage ~ $20,000.00

Money from leverage ~ $19,000.00


0.00004%
Overnight funding adjustment time21:00 (UTC)
CurrencyUSD
Min traded quantity0.1
Margin5.00%
Stock exchangeUnited States of America
Commission on trade10%
Guaranteed stop premium
A guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.
1%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close80.18
Open82.09
1-Year Change-27.83%
Day's Range80.96 - 83.58

Trade TransMedics Group Inc - TMDX

What is TransMedics Group Inc (TMDX)?

TransMedics Group Inc is a medical technology company specializing in the development and commercialization of organ transplant systems. The company focuses on innovative solutions designed to improve the preservation, assessment, and transportation of donor organs. Its flagship technology includes ex vivo organ perfusion systems that maintain organs in a near-physiological state outside the body, potentially increasing the viability and availability of organs for transplantation. TransMedics serves healthcare providers and transplant centers, aiming to address challenges associated with organ shortages and transplantation outcomes. The company's products are used primarily in the management of heart, lung, and kidney transplants. Founded with a mission to enhance the organ transplant process, TransMedics integrates advanced biomedical engineering and clinical research to support transplant teams worldwide. Its operations encompass research and development, regulatory affairs, and global distribution of its medical devices. The company contributes to the field of transplant medicine by enabling better organ preservation and assessment techniques.

TransMedics Group Inc Stock Price Today: Live Overview

The price today is shaped by active market trading, as TransMedics Group Inc holds at $82.28. Its price has fluctuated between $79.89 and $83.71, with a daily percent change of +2.4466%.

FAQ: TransMedics Group Inc (TMDX)

What is the current price of TMDX stock?

TransMedics Group Inc is currently priced at $82.28.

Does TMDX pay dividends?

TransMedics Group Inc does not pay dividends.

Does TMDX have a formal corporate presence or regional headquarters in the UAE?

TransMedics Group Inc operates in the UAE via partners and distributors without an official regional office or subsidiary.

What is TMDX best known for?

TransMedics Group Inc is most famous for its organ transplant technology.

What assets are typically shown together with TMDX?

Commonly shown alongside TMDX: Global X SuperDividend ETF, General Dynamics, Kerry PPT

Latest shares articles

A GameStop store in Portland, Oregon
GameStop stock forecast: debt exchange, Q2 profit
GameStop is a US video-game retailer. In Q2 fiscal 2026, net sales fell to $790.2m, while operating income rose to $160.2m. Explore third-party GME price targets and technical analysis. Past performance is not a reliable indicator of future results.
19 hours ago
Freenet stock forecast
Freenet stock forecast: revenue rises, EBITDA falls
Freenet reported first-half 2026 revenue of €1,512.9 million, up 24.7% year on year, while adjusted EBITDA fell 5.9% to €242.2 million and 2026 guidance was maintained. Explore third-party FNTN price targets and technicals. Past performance is not a reliable indicator of future results.
20 hours ago
Hims & Hers Health stock forecast
Hims & Hers Health stock forecast: FDA GLP-1 warning
Hims & Hers Health is a US telehealth company. In August 2026, the FDA issued a warning concerning unapproved compounded GLP-1 weight-loss drugs. Explore third-party HIMS price targets and technical analysis. Past performance is not a reliable indicator of future results.
20 hours ago
Arm Holdings stock forecast
Arm Holdings stock forecast: Haas flags AI demand
Arm Holdings is a UK-based semiconductor company. Chief executive Rene Haas said AI and data-centre demand showed no signs of slowing. Explore third-party ARM price targets and technical analysis. Past performance is not a reliable indicator of future results.
09:43, 6 October 2026

User feedback and ratings

2025-07-01
Victor Flemming Nandwa Søder

Great customer service I got to say that. They helped get my account back very fast, after i logged myself out by losing my old email, it was so fast you wouldn’t believe it thank you once again.

2025-07-01
Perry Reineke

I'm learning the basics of stock investing. This platform is clear and pretty good. I've been using it for over 6 months.

2025-06-29
proinpro

Capital is really great to be used on start, also beginner friendly broker! Great costumer support and it is quick!

2025-06-27
Gio Gvazava

Capital.com has been great for both learning and trading. The app is clean, fast, and packed with useful tools. Customer support has been solid too. Definitely recommended for beginners and active traders alike.

2025-06-27
Douglas

Deposits and withdrawals work without issues. Very low spreads. No noticeable fees. Easy to follow.

2025-06-22
Jean A.

The app is built to make options and figures easy to understand, great for beginners and intermediate traders. Demo accounts are simple to set up. 100:1 leverage is available.

2025-06-19
foobarbeer

I am extremely happy with this broker. Great spreads, good selection of instruments, well coded toolbox.

2025-06-19
Casaubon70

Love the TV integration. Makes traders life smooth and comfortable.

2025-06-19
dgogidze7

I would like to express a huge thank you to Evgeniya Logvinovich, customer service manager. For your attention and heartfelt attitude to your clients.❤️

2025-05-30
Brigman

Everything worked as expected from the 1 day. I didn’t have to search how to use the platform, it’s intuitive. The support chat was there when I had a tiny issue.

2025-05-24
Radioilluminati

I trade every day and Capital is my beloved home. I also create music and you can always feel when something has been created from the heart. Capital has soul!

2025-05-20
GemzT

I’d been paper trading for 2yrs now, went live and this platform is easy for beginners to understand and navigate all important tools to execute all that I learned. Earning now!

2025-04-29
dmjnoor

This application is perfect.. simple, easy to use, run smoothly and fast and it has an accurate graphics.. be careful to use only one credit card and one bank account to prevent any withdrawal problem.. overnight fees and spread variation will be repaid for you by the next month.. I used many application but this is the best one

2025-03-24
Debbie P

The best trading company I've found so far and so easy to use.

2025-02-06
Nouman Butt

User friendly app & interface and good support team. Funds transfer ease & Leverage is an advantage but crypto is highly risky be responsible of your loss limits and risks appetite.

Showing our 4 & 5 star reviews.

Ready to join a leading broker?

1. Create your account2. Make your first deposit3. Start when you’re ready